-+ 0.00%
-+ 0.00%
-+ 0.00%

ROIVANT SCIENCES SHARES DOWN 1.4% PREMARKET; CO ANNOUNCES TOPLINE RESULTS FROM PROOF-OF-CONCEPT STUDY OF IMVT-1402 IN CUTANEOUS LUPUS ERYTHEMATOSUS

Reuters·09/23/2026 11:03:49

Please log in to view news